Artificial intelligence (AI) appears as if it could be one of the game-changing technologies of this generation. Many of the ...

Patients in the Veritac-2 study were randomized to receive a standard estrogen blocker called fulvestrant, or Arvinas' vepdegestrant. If the experimental estrogen degrader delays tumor growth longer ...

risks associated with stretched tech-stock valuations and enormous spending by some of the biggest tech firms as they pursue their AI ambitions. The debut of the DeepSeek AI tool blindsided ...

Nebius shows massive growth potential with a 766% revenue increase in Q3 2024, driven by its AI infrastructure ... together gives me a $101.2 price target for NBIS stock. This price target however ...